Cell Well Ltd. is a company that develops and supplies cell-based products for hepatitis research, including a new human hepatocyte-like cell line called 4bHHl that is susceptible to hepatitis B virus (HBV) infection and can be used as a tool to study the HBV lifecycle and screen antiviral drugs and vaccines.